Could a simple vitamin save lives in the ICU?

NCT ID NCT03188796

First seen Nov 21, 2025 · Last updated Jun 23, 2026 · Updated 31 times

Summary

This study is testing whether giving high doses of vitamin D3 to critically ill patients with very low vitamin D levels can reduce the chance of death within 28 days. The trial will include 2,400 adults in intensive care units. If successful, this cheap and easy treatment could be quickly adopted worldwide.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COVID19 are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Barmherzige Brüder

    RECRUITING

    Vienna, Austria

    Contact

  • Barmherzige Schwestern

    RECRUITING

    Linz, Austria

    Contact

  • CHR Citadelle

    TERMINATED

    Liège, Belgium

  • CHU Ambroise Pare

    TERMINATED

    Mons, Belgium

  • CHU de Charleroi

    TERMINATED

    Charleroi, Belgium

  • Erasme Hospital

    TERMINATED

    Brussels, Belgium

  • Kaiser Franz Josef Spital Wien

    SUSPENDED

    Vienna, Austria

  • Kepler Universitätsklinikum Linz

    RECRUITING

    Linz, Austria

    Contact

  • Klinikum am Wörthersee

    RECRUITING

    Klagenfurt, Austria

    Contact

  • Krankenhaus Schwarzach

    TERMINATED

    Schwarzach im Pongau, Austria

  • LKH Enzenbach

    RECRUITING

    Enzenbach, Austria

    Contact

  • LKH Feldbach

    TERMINATED

    Feldbach, Austria

  • LKH Hochsteiermark Standort Leoben

    RECRUITING

    Leoben, Austria

    Contact

  • LKH Villach

    RECRUITING

    Villach, Austria

    Contact

  • Medical University of Graz

    RECRUITING

    Graz, Austria

    Contact

  • Medical University of Vienna

    RECRUITING

    Vienna, Austria

    Contact

  • University Hospital Wuerzburg

    RECRUITING

    Würzburg, Germany

    Contact

  • University of Birmingham

    RECRUITING

    Birmingham, United Kingdom

    Contact

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Vitamin D3 (cholecalciferol)

What this could lead to

If it works, this could provide a simple, inexpensive way to lower death rates in critically ill patients with severe vitamin D deficiency.

What could go wrong

This is a confirmatory trial, but the earlier study was small and the benefit was seen only in a subgroup. There is also a risk of side effects like high calcium levels.

Conditions

The condition(s) this trial relates to.

COVID-19 Critical Illness vitamin D deficiency

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.